RESUMEN
Oral carcinogenesis is a multifactorial process involving numerous genetic events that alter normal functions of oncogenes and tumour suppressor genes. This may increase the production of growth factors or the number of receptors on the cell surface, and/or increase transcription factors or intracellular signal messengers. Together with the loss of tumour suppressor activity, these changes lead to a cell phenotype that can increase cell proliferation, with loss of cell cohesion, and infiltration of adjacent tissue thus causing distant metastasis. Molecular pathology is responsible for defining the molecular mechanisms that underlie the onset of oral precancer and cancer. The aim of this review is to describe recent advances in our understanding of the molecular control of the innumerable pathways related to these processes. These may lead to short- or medium term improvements in the diagnosis and prognosis of oral precancerous and cancerous lesions and to the development of novel therapeutic approaches to this disease.
Asunto(s)
Neoplasias de la Boca/genética , Neoplasias de la Boca/patología , Lesiones Precancerosas/genética , Lesiones Precancerosas/patología , Progresión de la Enfermedad , Humanos , Neoplasias de la Boca/virología , Lesiones Precancerosas/virologíaRESUMEN
BACKGROUND: A double-blind placebo-controlled trial was conducted in order to evaluate the efficacy of alpha lipoic acid (ALA) and determine the statistical significance of the outcome variables. Burning mouth syndrome (BMS) is defined as an oral burning sensation in the absence of clinical signs which could justify the syndrome. Recent studies suggest the existence of neurological factors as a possible cause of the disease. MATERIAL AND METHODS: 60 patients with BMS, in two groups: case group with 600 mg/day and placebo as control group; with follow up of 2 months. RESULTS: 64% of ALA patients reported some level of improvement, with a level of maintenance of 68.75% one month after treatment. 27.6% of the placebo group also demonstrated some reduction in BMS symptoms. CONCLUSIONS: Long-term evolution and the intensity of symptoms are variables that reduce the probability of improvement with ALA treatment
No disponible
Asunto(s)
Adulto , Anciano de 80 o más Años , Anciano , Femenino , Humanos , Masculino , Ácido Tióctico/uso terapéutico , Síndrome de Boca Ardiente/diagnóstico , Síndrome de Boca Ardiente/tratamiento farmacológico , Resultado del Tratamiento , Síndrome de Boca Ardiente/fisiopatología , Lengua , Lengua/patologíaRESUMEN
Estudios recientes han demostrado la capacidad del organismo humano para detener el crecimiento de potenciales células cancerígenas y paralizarlas. Este mecanismo antitumoral, que actúa como freno del proceso maligno, se conocía ya en estudios de laboratorio in vitro, pero se ha comprobado también su presencia en modelos in vivo, tanto en ratones como en muestras de tejido de pacientes con cáncer. A este mecanismo se le denomina senescencia celular y se define como un sistema de defensa de emergencia de las células que están en camino de convertirse en cancerosas, una respuesta ante el estímulo de un oncogén. Se trataría pues de un freno a la progresión de las lesiones cancerizables, condenando a esas células a una cadena perpetua celular. Este artículo de revisión se propone describir este mecanismo y poner al día la evidencia al respecto de este proceso, así como los marcadores de senescencia existentes en relación con el cáncer y precáncer oral This article reviews the paper of oral biopsy on the precancerous lesions diagnosis and on the oral cancer early diagnosis. Different techniques, procedures, materials, indications and other surgical aspects are debated. It proposes to do incisional biopsies on malignant lesions and on malignant suspicious lesions, while doing excisional biopsies on precancerous lesions when the size allows it ( AU)
Recent studies have demonstrated the capacity of the human organism to prevent the growth of potentially carcinogenic cells, paralyzing them. This antitumor mechanism, which acts as a brake on the malignant process, was already known in lab studies in vitro but has now also been verified in vivo in mice and in tissue samples from cancer patients. This mechanism is known as cellular senescence and is defined as an emergency defense system for cells on the way to becoming cancerous, i.e., a response to the stimulation of an oncogene. These cells are sentenced to life imprisonment, impeding the progression of premalignant lesions. This review aims to describe this mechanism and present an update of the evidence on this phenomenon in the setting of oral cancer and precance This article reviews the paper of oral biopsy on the precancerous lesions diagnosis and on the oral cancer early diagnosis. Different techniques, procedures, materials, indications and other surgical aspects are debated. It proposes to do incisional biopsies on malignant lesions and on malignant suspicious lesions, while doing excisional biopsies on precancerous lesions when the size allows it (AU)